Details for New Drug Application (NDA): 075028
✉ Email this page to a colleague
NDA 075028 describes PENTOXIFYLLINE, which is a drug marketed by Ani Pharms, Apotex, Bausch, Heritage, Impax Labs, Pliva, and Rising, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the PENTOXIFYLLINE profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 075028
| Tradename: | PENTOXIFYLLINE |
| Applicant: | Bausch |
| Ingredient: | pentoxifylline |
| Patents: | 0 |
Pharmacology for NDA: 075028
| Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for 075028
Suppliers and Packaging for NDA: 075028
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075028 | ANDA | NuCare Pharmaceuticals,Inc. | 68071-4532 | 68071-4532-9 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-4532-9) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
| Approval Date: | Jul 20, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
